Neuropace, Inc. (NPCE)
Nasdaq: NPCE · Surgical & Medical Instruments & Apparatus · Mountain View, CA · filing with the SEC since 2011
Who owns Neuropace, Inc.
As filed with the SECHolders of 5% or more
5
Mathew P. Arens holds 12.3% of Common Stock, $0.01 par value, as its SCHEDULE 13G/A filed Sep 4, 2026 says.
Directors and officers
10
report now, of 15 people on the record since 2021. Their holdings as a group are not read here.
Institutions as a whole
n/a
The record does not read the share held by managers that file Form 13F, so none is printed and no split of the rest is estimated. What it holds is the 5 named at left.
Holders of 5% or moreshare of the class, as filed
Mathew P. Arens
SCHEDULE 13G/A · filed Sep 4, 2026 · Common Stock, $0.01 par value · 8.67% in May 15, 2026
Polar Capital Holdings Plc
SCHEDULE 13G · filed May 15, 2025 · Common Stock, $0.001 par value per share
Soleus Capital Management, L.P.
SCHEDULE 13G/A · filed Nov 7, 2025 · Common Stock, par value $0.001 per share
Morgan Stanley
SCHEDULE 13G/A · filed Feb 4, 2025 · Common Stock
Soleus Capital Management, L.P.
SCHEDULE 13G/A · filed Aug 5, 2025 · Common Stock, par value $0.001 per share
Kent Lake PR LLC
SCHEDULE 13G/A · filed Feb 14, 2025 · Common Stock, .001 par value per share · reported falling below 5%, from 5% in Nov 4, 2024
OrbiMed Advisors LLC
SCHEDULE 13G/A · filed Aug 14, 2026 · Common Stock, par value $0.001 per share · reported falling below 5%, from 6.2% in May 15, 2026
Kck Ltd.
SCHEDULE 13G/A · filed Sep 3, 2025 · Common Stock, $0.001 par value per share · reported falling below 5%, from 17.7% in Feb 11, 2025
What NPCE reports owning in othersstakes of 5% or more, and other ties
Neuropace, Inc. reports no stake in another company in the record.
Insider tradesForm 4
1sales
0purchases
0sales on a scheduled plan
1people selling
$400,000sold, in dollars
$0bought, in dollars
Open-market trades on Form 4 from Sep 30, 2025 to Sep 30, 2026. A scheduled plan is a selling program set in advance under SEC rule 10b5-1. The trades are listed as filed and do not feed the grade.
By calendar yearSoldBought
2025 runs to Sep 30, 2026. Dollars as filed, summed by the transaction date.
People who traded in the window1 of 19 on the roster
| Person | Role as filed | Sales | Sold | On a plan | Buys | Bought |
|---|---|---|---|---|---|---|
| Morrell Martha | CHIEF MEDICAL OFFICER | 1 | $400,000 | 0 | 0 | $0 |